Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
36 studies found for:    Guillain-Barré Syndrome
Show Display Options
RSS Create an RSS feed from your search for:
Guillain-Barré Syndrome
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting International Guillain-Barré Syndrome Outcome Study
Conditions: Guillain-Barré Syndrome;   Miller Fisher Syndrome
Intervention:
2 Completed Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)
Condition: Guillain Barre Syndrome
Interventions: Drug: IVIG;   Procedure: Plasma Exchange
3 Recruiting sCD163 as a Potential Biomarker in Guillain- Barré Syndrome
Condition: Guillain-Barre Syndrome
Interventions: Procedure: Lumbar puncture;   Procedure: Blood Sample
4 Suspended Gastrointestinal Transit Time in Patients With Guillain-Barré Syndrome
Conditions: Guillain-Barre Syndrome;   Constipation
Intervention:
5 Unknown  Safety Study of GBS Following Menactra Meningococcal Vaccination
Condition: Guillain-Barre Syndrome
Intervention:
6 Completed Early Mechanical Ventilation for Guillain Barré Syndrome
Conditions: Guillain Barré Syndrome;   Acute Respiratory Failure
Interventions: Procedure: mechanical ventilation;   Procedure: physiotherapy and oxygen if needed
7 Completed Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome
Condition: Guillain-Barré Syndrome
Intervention: Drug: GB-0998
8 Unknown  The Changes of Cytokines in Guillain Barré Syndrome: the Correlation With Clinical Manifestations and Skin Innervation
Condition: Guillain Barré Syndrome
Intervention:
9 Recruiting Small Volume Plasma Exchange (SVPE) for Guillain-Barré Syndrome (GBS) Patients
Condition: Guillain-Barré Syndrome
Intervention: Procedure: Small Volume Plasma Exchange
10 Completed Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine
Condition: Guillain-Barre Syndrome
Intervention: Drug: 4-aminopyridine (4-AP)
11 Terminated Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
Condition: Guillain-Barre Syndrome
Intervention: Drug: Immune globulin
12 Completed Prospective Study on Swallowing/Breathing Interactions in Severe Guillain Barre Syndrome.
Conditions: Tetraplegia;   Respiratory Failure
Intervention:
13 Unknown  Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome
Condition: Guillain-Barré Syndrome
Intervention: Drug: NPB-01
14 Completed Effects of Robotic-assisted Gait Training In Non-Ambulatory Patients After Guillain-Barré Syndrome
Condition: GBS
Interventions: Device: Robot-assisted Gait Training;   Other: conventional rehabilitation
15 Unknown  Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study
Condition: Gullian Barre Syndrome
Intervention: Drug: Eculizumab
16 Completed Brain Computer Interface for Communication in ICU: a Feasibility Study
Conditions: Tetraplegia;   Guillain-Barre Syndrome
Intervention:
17 Active, not recruiting JET-GBS - Japanese Eculizumab Trial for GBS
Condition: Gullain Barre Syndrome
Interventions: Drug: Eculizumab;   Drug: Placebo
18 Active, not recruiting Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
Conditions: Guillain-Barre Syndrome;   CIDP;   Multifocal Motor Neuropathy
Intervention:
19 Completed Regional Citrate Anticoagulation in Plasma Exchange Treatment
Conditions: Focal Segmental Glomerulosclerosis;   Guillain-Barre Syndrome
Intervention: Procedure: plasma exchange treatment
20 Enrolling by invitation Comparative Autoantibody and Immunologic Cell Marker Study
Conditions: Autoimmune Diseases;   Lupus Erythematosus, Systemic;   Communicable Diseases
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results    Last Page
Indicates status has not been verified in more than two years